P2 Receptors as Therapeutic Targets in the Salivary Gland: From Physiology to Dysfunction

Frontiers in Pharmacology- Switzerland

doi 10.3389/fphar.2020.00222

Full Text

Abstract

Available in

Categories

Date

March 13, 2020

Authors

Mahmoud G. Khalafalla

Kimberly J. Jasmer

Kevin Muñoz Forti

Janicke L. Jensen

Kirsten H. Limesand

Hilde K. Galtung

Gary A. Weisman

Publisher

Frontiers Media SA

Related search

Chemokine Receptors as Therapeutic Targets

Japanese Journal of Clinical Immunology

English

Eph Receptors as Therapeutic Targets in Glioblastoma

British Journal of Cancer

Cancer Research

English

P2X Receptors as New Therapeutic Targets

English

Sigma Receptors as Potential Therapeutic Targets for Neuroprotection

European Journal of Pharmacology

English

Liver X Receptors as Potential Therapeutic Targets in Atherosclerosis

Clinical and Investigative Medicine

English

Salivary Gland Progenitor Cell Biology Provides a Rationale for Therapeutic Salivary Gland Regeneration

Otorhinolaryngology

English

Radiation-Induced Salivary Gland Dysfunction Results From P53-Dependent Apoptosis

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English

Steroid Hormone Receptors in Human Salivary Gland Tumours.

Journal of Clinical Pathology

Forensic Medicine

English

Glutamate and Its Receptors as Therapeutic Targets for Migraine

Neurotherapeutics

English